Initial Management of Elevated Amylase and Lipase
When amylase and lipase are elevated, immediately assess for acute pancreatitis by confirming levels are >3 times the upper limit of normal, obtaining abdominal ultrasound to identify gallstones, and stratifying severity using APACHE II scoring (cutoff of 8) to determine need for ICU admission. 1
Immediate Diagnostic Steps
Confirm Pancreatic Etiology
- Verify enzyme elevation is significant (>3× upper limit of normal), which provides optimal balance between sensitivity (84-92%) and specificity (98%) for acute pancreatitis 1, 2
- Lipase is the preferred single test over amylase due to higher sensitivity and longer diagnostic window (elevated 8-14 days vs 3-7 days for amylase) 1, 3
- If only one enzyme can be ordered, choose lipase alone—co-ordering both tests provides minimal additional diagnostic value 3
- Elevations <3× upper limit can occur in non-pancreatic conditions (renal disease, appendicitis, cholecystitis, bowel obstruction) but significant elevations are uncommon in these disorders 1, 4
Clinical Assessment
- Look specifically for: upper abdominal pain with radiation to the back, nausea/vomiting, epigastric tenderness on examination 1
- In trauma patients, check for: lower rib fractures, upper abdominal ecchymosis, supra-umbilical seat belt sign, upper lumbar spine fractures 5
- Clinical assessment alone misclassifies approximately 50% of patients, so biochemical and imaging confirmation is essential 1
Essential Imaging
First-Line Ultrasound
- Perform abdominal ultrasound immediately in all suspected cases to detect gallstones, free peritoneal fluid, or biliary duct dilation 1
- This identifies the most common etiology (gallstone pancreatitis) and guides urgent ERCP consideration 1
CT Scanning Indications
- Order contrast-enhanced CT if: clinical/biochemical findings are inconclusive, APACHE II score >8, or organ failure is present 1
- Critical timing: perform CT after 72 hours of symptom onset to avoid underestimating pancreatic necrosis 1
- For deteriorating patients with high clinical suspicion but negative initial imaging, repeat CT within 12-24 hours 1
Severity Stratification
Use Validated Scoring Systems
- Apply APACHE II score immediately (preferred cutoff of 8) rather than relying on enzyme levels, which do not predict severity 1
- Alternative markers: C-reactive protein >150 mg/L, Glasgow score ≥3, or persisting organ failure after 48 hours 1
- The degree of enzyme elevation is independent of disease severity—even mild elevations can indicate severe pancreatitis 1
Disposition Decisions
- Admit to ICU if APACHE II >8 or evidence of organ failure 1
- Serial clinical examinations are more important than trending enzyme levels for monitoring disease progression 1
Etiology Workup
Identify Underlying Cause
- If gallstones detected on ultrasound: consider urgent ERCP in severe pancreatitis 1
- If no gallstones and no significant alcohol history: measure serum triglycerides and calcium 1
- Triglyceride levels >1000 mg/dL (>11.3 mmol/L) confirm hypertriglyceridemia as etiology 1
Trauma-Specific Considerations
- In blunt/penetrating abdominal trauma with suspected pancreatic injury, measure enzymes every 6 hours starting 3-6 hours post-injury for improved accuracy 5
- Persistently elevated or rising levels indicate need for advanced imaging (CT or ERCP) 5
- Normal amylase at admission occurs in up to 40% of pancreatic trauma cases 5
Common Pitfalls to Avoid
- Do not wait for enzyme levels to normalize before initiating treatment—management is based on clinical parameters, not enzyme trends 1
- Do not perform early CT (<72 hours) unless clinically deteriorating, as it underestimates necrosis 1
- Do not use enzyme levels to determine timing of oral feeding or discharge—use clinical resolution of pain and tolerance of oral intake instead 1
- Do not delay diagnostic laparotomy in hemodynamically unstable trauma patients with equivocal imaging 5
- Avoid misinterpreting persistent lipase elevation as treatment failure, as it can remain elevated 8-14 days with appropriate treatment 1